[Anidulafungin: experimental therapy of fungal infections in animal models]

Area of Science:

• Mycology
• Pharmacology
• Infectious Diseases

Background:

• Anidulafungin is the latest echinocandin antifungal agent.
• Published data on its efficacy is limited, primarily focusing on invasive aspergillosis and candidiasis.
• Understanding its activity spectrum is crucial for clinical application.

Purpose of the Study:

• To review existing data on the efficacy of anidulafungin.
• To summarize its activity against key fungal pathogens.
• To assess its potential role in managing fungal infections.

Main Methods:

• Literature review of published studies on anidulafungin.
• Analysis of reported in vitro and in vivo data.
• Synthesis of efficacy findings against Aspergillus and Candida species.

Main Results:

• Anidulafungin exhibits fungistatic activity against Aspergillus fumigatus.
• Anidulafungin demonstrates fungicidal activity against Candida albicans and Candida glabrata.
• Current data is predominantly on disseminated and pulmonary aspergillosis and disseminated candidiasis.

Conclusions:

• Anidulafungin possesses a defined spectrum of activity against common fungal pathogens.
• Its fungicidal action against Candida species suggests therapeutic potential.
• Further research is warranted to fully elucidate its role in treating invasive fungal infections.